Moderna
MRNA
#1638
Rank
โ‚น1.146 T
Marketcap
โ‚น2,935
Share price
1.42%
Change (1 day)
-14.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น50.54 M-67.66%
2024โ‚น0.15 B15.08%
2023โ‚น0.13 B-50.15%
2022โ‚น0.27 B-85.7%
2021โ‚น1.90 B158.2%
2020โ‚น0.73 B369.18%
2019โ‚น0.15 B1011.49%
2018โ‚น14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regulus Therapeutics
RGLS
N/Aโ‚น5.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น17.08 Mโ‚น0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น0.09 Mโ‚น0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น8.65 Mโ‚น41.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น19.76 Mโ‚น75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚น2.01 Mโ‚น7.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น57.52 Mโ‚น0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA